Kolla Bhanu Prakash, Schneekloth Terry D, Biernacka Joanna, Shah Vijay, Lazaridis Konstantinos N, Geske Jennifer, Karpyak Victor
Department of Psychiatry and Psychology, Mayo Clinic, 2nd Street SW, Rochester, MN, USA.
Department of Biostatistics, Mayo Clinic, 2nd Street SW, Rochester, MN, USA.
Alcohol Alcohol. 2018 Jul 1;53(4):357-360. doi: 10.1093/alcalc/agy007.
Prior studies have established variation at the PNPLA3 gene to be associated with a risk of developing alcoholic liver disease (ALD). We attempt to replicate this finding and other potential genetic variations previously associated with ALD utilizing a case-control design in a cohort of subjects with alcohol use disorders.
This case-control study performed in a US clinical sample of heavy drinkers, replicates the previously reported association between ALD and rs738409 polymorphism in the PNPLA3 gene in heavy drinkers. This association persisted after accounting for the subject's diabetes status.
Patients of European ancestry with a history of ALD were identified (n = 169). Controls consisted of patients without ALD who were from the same cohorts and were ≥ 30 years of age, had lifetime total years drinking ≥20 and lifetime maximum drinks per day ≥12 (n = 259). Patients were genotyped for 40 candidate single nucleotide polymorphisms (SNPs) selected for the purpose of testing their association with ALD. The association of each SNP with ALD was tested using a logistic regression model, assuming log-additive allele effects. Bonferroni correction was applied and multivariable logistic regression models were used to account for relevant covariates.
Age, sex, and body mass index (BMI) distributions were similar between cases and controls. Diabetes was more prevalent in the ALD cases. Three SNPs were associated with ALD at the nominal significance level (rs738409 in PNPLA3, P = 0.00029; rs3741559 in AQP2, P = 0.0185; rs4290029 in NVL, P = 0.0192); only PNPLA3 rs738409 SNP was significant at the Bonferroni-corrected P-value threshold of 0.00125. Association results remained significant after adjustment for diabetes status.
Our case-control study confirmed that PNPLA3 rs738409 SNP is associated with ALD. This is an important replication in a US clinical sample with control subjects who had long histories of alcohol consumption.
先前的研究已证实PNPLA3基因的变异与酒精性肝病(ALD)的发生风险相关。我们试图通过病例对照设计,在一组患有酒精使用障碍的受试者中重复这一发现以及其他先前与ALD相关的潜在基因变异。
这项在美国重度饮酒者临床样本中进行的病例对照研究,重复了先前报道的重度饮酒者中ALD与PNPLA3基因rs738409多态性之间的关联。在考虑受试者的糖尿病状态后,这种关联仍然存在。
确定有ALD病史的欧洲血统患者(n = 169)。对照组由来自同一队列、年龄≥30岁、终生饮酒总年数≥20且终生每日最大饮酒量≥12的无ALD患者组成(n = 259)。对患者进行40个候选单核苷酸多态性(SNP)的基因分型,这些SNP是为了测试它们与ALD的关联而选择的。使用逻辑回归模型测试每个SNP与ALD的关联,假设对数加性等位基因效应。应用Bonferroni校正,并使用多变量逻辑回归模型来考虑相关协变量。
病例组和对照组之间的年龄、性别和体重指数(BMI)分布相似。糖尿病在ALD病例中更为普遍。三个SNP在名义显著性水平上与ALD相关(PNPLA3中的rs738409,P = 0.00029;AQP2中的rs3741559,P = 0.0185;NVL中的rs4290029,P = 0.0192);只有PNPLA3 rs738409 SNP在Bonferroni校正的P值阈值0.00125时具有显著性。在调整糖尿病状态后,关联结果仍然显著。
我们的病例对照研究证实PNPLA3 rs738409 SNP与ALD相关。这是在美国临床样本中,对有长期饮酒史的对照受试者进行的一项重要重复研究。